| Year |
Citation |
Score |
| 2024 |
Wojtas AM, Dammer EB, Guo Q, Ping L, Shantaraman A, Duong DM, Yin L, Fox EJ, Seifar F, Lee EB, Johnson ECB, Lah JJ, Levey AI, Levites Y, Rangaraju S, et al. Proteomic Changes in the Human Cerebrovasculature in Alzheimer's Disease and Related Tauopathies Linked to Peripheral Biomarkers in Plasma and Cerebrospinal Fluid. Medrxiv : the Preprint Server For Health Sciences. PMID 38260316 DOI: 10.1101/2024.01.10.24301099 |
0.322 |
|
| 2023 |
Levites Y, Dammer EB, Ran Y, Tsering W, Duong D, Abreha M, Gadhavi J, Lolo K, Trejo-Lopez J, Phillips JL, Iturbe A, Erqiuzi A, Moore BD, Ryu D, Natu A, et al. Aβ Amyloid Scaffolds the Accumulation of Matrisome and Additional Proteins in Alzheimer's Disease. Biorxiv : the Preprint Server For Biology. PMID 38076912 DOI: 10.1101/2023.11.29.568318 |
0.389 |
|
| 2022 |
Moore BD, Levites Y, Xu G, Hampton H, Adamo MF, Croft CL, Futch HS, Moran C, Fromholt S, Janus C, Prokop S, Dickson D, Lewis J, Giasson BI, Golde TE, et al. Soluble brain homogenates from diverse human and mouse sources preferentially seed diffuse Aβ plaque pathology when injected into newborn mouse hosts. Free Neuropathology. 3. PMID 35494163 DOI: 10.17879/freeneuropathology-2022-3766 |
0.401 |
|
| 2022 |
Marino M, Zhou L, Rincon MY, Callaerts-Vegh Z, Verhaert J, Wahis J, Creemers E, Yshii L, Wierda K, Saito T, Marneffe C, Voytyuk I, Wouters Y, Dewilde M, Duqué SI, ... ... Levites Y, et al. AAV-mediated delivery of an anti-BACE1 VHH alleviates pathology in an Alzheimer's disease model. Embo Molecular Medicine. 14: e09824. PMID 35352880 DOI: 10.15252/emmm.201809824 |
0.339 |
|
| 2022 |
Aravindraja C, Sakthivel R, Liu X, Goodwin M, Veena P, Godovikova V, Fenno JC, Levites Y, Golde TE, Kesavalu L. Intracerebral but Not Peripheral Infection of Live Exacerbates Alzheimer's Disease Like Amyloid Pathology in APP-TgCRND8 Mice. International Journal of Molecular Sciences. 23. PMID 35328748 DOI: 10.3390/ijms23063328 |
0.368 |
|
| 2021 |
Levites Y, Funk C, Wang X, Chakrabarty P, McFarland KN, Bramblett B, O'Neal V, Liu X, Ladd T, Robinson M, Allen M, Carrasquillo MM, Dickson D, Cruz P, Ryu D, et al. Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapy. Molecular Neurodegeneration. 16: 32. PMID 33957936 DOI: 10.1186/s13024-021-00453-4 |
0.328 |
|
| 2021 |
Saha J, Dean DN, Dhakal S, Stockmal KA, Morgan SE, Dillon KD, Adamo MF, Levites Y, Rangachari V. Biophysical characteristics of lipid-induced Aβ oligomers correlate to distinctive phenotypes in transgenic mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 35: e21318. PMID 33508158 DOI: 10.1096/fj.202002025RR |
0.375 |
|
| 2020 |
Goodwin MS, Sinyavskaya O, Burg F, O'Neal V, Ceballos-Diaz C, Cruz PE, Lewis J, Giasson BI, Davies P, Golde TE, Levites Y. Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 33128896 DOI: 10.1016/j.ymthe.2020.10.007 |
0.316 |
|
| 2020 |
De Mena L, Smith MA, Martin J, Dunton KL, Ceballos-Diaz C, Jansen-West KR, Cruz PE, Dillon KD, Rincon-Limas DE, Golde TE, Moore BD, Levites Y. Aß40 displays amyloidogenic properties in the non-transgenic mouse brain but does not exacerbate Aß42 toxicity in Drosophila. Alzheimer's Research & Therapy. 12: 132. PMID 33069251 DOI: 10.1186/s13195-020-00698-z |
0.353 |
|
| 2020 |
Wan YW, Al-Ouran R, Mangleburg CG, Perumal TM, Lee TV, Allison K, Swarup V, Funk CC, Gaiteri C, Allen M, Wang M, Neuner SM, Kaczorowski CC, Philip VM, Howell GR, ... ... Levites Y, et al. Meta-Analysis of the Alzheimer's Disease Human Brain Transcriptome and Functional Dissection in Mouse Models. Cell Reports. 32: 107908. PMID 32668255 DOI: 10.1016/J.Celrep.2020.107908 |
0.449 |
|
| 2020 |
Liu G, Fiock KL, Levites Y, Golde TE, Hefti MM, Lee G. Fyn depletion ameliorates tau-induced neuropathology. Acta Neuropathologica Communications. 8: 108. PMID 32665013 DOI: 10.1186/S40478-020-00979-6 |
0.474 |
|
| 2020 |
Xu G, Fromholt SE, Chakrabarty P, Zhu F, Liu X, Pace MC, Koh J, Golde TE, Levites Y, Lewis J, Borchelt DR. Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis. Acta Neuropathologica Communications. 8: 43. PMID 32252825 DOI: 10.1186/S40478-020-00911-Y |
0.486 |
|
| 2019 |
Forner S, Martini AC, Prieto GA, Dang CT, Rodriguez-Ortiz CJ, Reyes-Ruiz JM, Trujillo-Estrada L, da Cunha C, Andrews EJ, Phan J, Vu Ha J, Chang AVZD, Levites Y, Cruz PE, Ager R, et al. Intra- and extracellular β-amyloid overexpression via adeno-associated virus-mediated gene transfer impairs memory and synaptic plasticity in the hippocampus. Scientific Reports. 9: 15936. PMID 31685865 DOI: 10.1038/S41598-019-52324-0 |
0.441 |
|
| 2019 |
Colon-Perez LM, Ibanez KR, Suarez M, Torroella K, Acuna K, Ofori E, Levites Y, Vaillancourt DE, Golde TE, Chakrabarty P, Febo M. Neurite orientation dispersion and density imaging reveals white matter and hippocampal microstructure changes produced by Interleukin-6 in the TgCRND8 mouse model of amyloidosis. Neuroimage. 202: 116138. PMID 31472250 DOI: 10.1016/J.Neuroimage.2019.116138 |
0.381 |
|
| 2019 |
Dhillon JS, Trejo-Lopez JA, Riffe C, Levites Y, Sacino AN, Borchelt DR, Yachnis AY, Giasson BI. Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils. Acta Neuropathologica Communications. 7: 80. PMID 31109378 DOI: 10.1186/S40478-019-0733-3 |
0.412 |
|
| 2019 |
Croft CL, Cruz PE, Ryu DH, Ceballos-Diaz C, Strang KH, Woody BM, Lin WL, Deture M, Rodríguez-Lebrón E, Dickson DW, Chakrabarty P, Levites Y, Giasson BI, Golde TE. rAAV-based brain slice culture models of Alzheimer's and Parkinson's disease inclusion pathologies. The Journal of Experimental Medicine. PMID 30770411 DOI: 10.1084/Jem.20182184 |
0.443 |
|
| 2019 |
Liu G, Levites Y, Golde TE, Lee G. P4-157: ROLE OF FYN IN A MOUSE MODEL OF TAU P301L TAUOPATHY Alzheimer's & Dementia. 15: P1334-P1335. DOI: 10.1016/J.Jalz.2019.06.3819 |
0.348 |
|
| 2018 |
Hamm M, Ladd TB, Levites Y, Golde TE, Giasson BI, Lewis J. Designing antibodies against LRRK2-targeted tau epitopes. Plos One. 13: e0204367. PMID 30261006 DOI: 10.1371/Journal.Pone.0204367 |
0.379 |
|
| 2018 |
Croft CL, Moore BD, Ran Y, Chakrabarty P, Levites Y, Golde TE, Giasson BI. Novel monoclonal antibodies targeting the microtubule-binding domain of human tau. Plos One. 13: e0195211. PMID 29608591 DOI: 10.1371/Journal.Pone.0195211 |
0.435 |
|
| 2017 |
Moore BD, Martin J, de Mena L, Sanchez J, Cruz PE, Ceballos-Diaz C, Ladd TB, Ran Y, Levites Y, Kukar TL, Kurian JJ, McKenna R, Koo EH, Borchelt DR, Janus C, et al. Short Aβ peptides attenuate Aβ42 toxicity in vivo. The Journal of Experimental Medicine. PMID 29208777 DOI: 10.1084/Jem.20170600 |
0.451 |
|
| 2017 |
Strang KH, Goodwin MS, Riffe C, Moore BD, Chakrabarty P, Levites Y, Golde TE, Giasson BI. Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau. Acta Neuropathologica Communications. 5: 58. PMID 28760159 DOI: 10.1186/S40478-017-0458-0 |
0.446 |
|
| 2017 |
Dean DN, Das PK, Rana P, Burg F, Levites Y, Morgan SE, Ghosh P, Rangachari V. Strain-specific Fibril Propagation by an Aβ Dodecamer. Scientific Reports. 7: 40787. PMID 28098204 DOI: 10.1038/Srep40787 |
0.408 |
|
| 2017 |
Croft CL, Cruz PE, Goodwin MS, Ceballos-Diaz C, Strang K, Chakrabarty P, Levites Y, Giasson BI, Golde TE. [P4-094]: TARGETING TAU AGGREGATION IN BRAIN SLICE CULTURE MODELS OF TAUOPATHIES Alzheimer's & Dementia. 13: P1294-P1294. DOI: 10.1016/J.Jalz.2017.06.1959 |
0.372 |
|
| 2016 |
Fernandez-Funez P, Sanchez-Garcia J, de Mena L, Zhang Y, Levites Y, Khare S, Golde TE, Rincon-Limas DE. Holdase activity of secreted Hsp70 masks amyloid-β42 neurotoxicity in Drosophila. Proceedings of the National Academy of Sciences of the United States of America. PMID 27531960 DOI: 10.1073/Pnas.1608045113 |
0.446 |
|
| 2016 |
Moore BD, Martin J, de Mena L, Levites Y, Ceballos-Diaz C, Cruz PE, Janus C, Rincon-Limas DE, Fernandez-Funez P, Golde TE. P1-165: Evidence to Support γ-Secretase Modulators: Short Aβ Peptides are Protective in Vivo Alzheimer's & Dementia. 12: P466-P466. DOI: 10.1016/J.Jalz.2016.06.913 |
0.345 |
|
| 2015 |
Montgomery KS, Edwards G, Levites Y, Kumar A, Myers CE, Gluck MA, Setlow B, Bizon JL. Deficits in hippocampal-dependent transfer generalization learning accompany synaptic dysfunction in a mouse model of amyloidosis. Hippocampus. PMID 26418152 DOI: 10.1002/Hipo.22535 |
0.329 |
|
| 2015 |
Fernandez-Funez P, Zhang Y, Sanchez-Garcia J, de Mena L, Khare S, Golde TE, Levites Y, Rincon-Limas DE. Anti-Aβ single chain variable fragment antibodies exert synergistic neuroprotective activities in Drosophila models of Alzheimer's disease. Human Molecular Genetics. PMID 26253732 DOI: 10.1093/Hmg/Ddv321 |
0.482 |
|
| 2015 |
Li A, Ceballos-Diaz C, DiNunno N, Levites Y, Cruz PE, Lewis J, Golde TE, Chakrabarty P. IFN-γ promotes τ phosphorylation without affecting mature tangles. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 26156074 DOI: 10.1096/Fj.15-275834 |
0.337 |
|
| 2015 |
Levites Y, O'Nuallain B, Puligedda RD, Ondrejcak T, Adekar SP, Chen C, Cruz PE, Rosario AM, Macy S, Mably AJ, Walsh DM, Vidal R, Solomon A, Brown D, Rowan MJ, et al. A human monoclonal IgG that binds aβ assemblies and diverse amyloids exhibits anti-amyloid activities in vitro and in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 6265-76. PMID 25904780 DOI: 10.1523/Jneurosci.5109-14.2015 |
0.488 |
|
| 2015 |
Golde T, Levites Y, Cruz PE, Rosario AM, Chakrabarty P, Moran C, Liu X, Ceballos-Diaz C, Moore B, Price ND, Funk C. O1-11-03: Modulating chemokine signaling in preclinical Alzheimer's disease models Alzheimer's & Dementia. 11: P157-P157. DOI: 10.1016/J.Jalz.2015.07.089 |
0.331 |
|
| 2014 |
Kim JY, Grunke SD, Levites Y, Golde TE, Jankowsky JL. Intracerebroventricular viral injection of the neonatal mouse brain for persistent and widespread neuronal transduction. Journal of Visualized Experiments : Jove. 51863. PMID 25286085 DOI: 10.3791/51863 |
0.327 |
|
| 2013 |
Sacino AN, Brooks M, McGarvey NH, McKinney AB, Thomas MA, Levites Y, Ran Y, Golde TE, Giasson BI. Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein. Acta Neuropathologica Communications. 1: 38. PMID 24252149 DOI: 10.1186/2051-5960-1-38 |
0.424 |
|
| 2013 |
Chakrabarty P, Rosario A, Cruz P, Siemienski Z, Ceballos-Diaz C, Crosby K, Jansen K, Borchelt DR, Kim JY, Jankowsky JL, Golde TE, Levites Y. Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain. Plos One. 8: e67680. PMID 23825679 DOI: 10.1371/Journal.Pone.0067680 |
0.319 |
|
| 2013 |
Clippinger AK, D'Alton S, Lin WL, Gendron TF, Howard J, Borchelt DR, Cannon A, Carlomagno Y, Chakrabarty P, Cook C, Golde TE, Levites Y, Ranum L, Schultheis PJ, Xu G, et al. Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy. Acta Neuropathologica. 126: 39-50. PMID 23666556 DOI: 10.1007/S00401-013-1123-8 |
0.365 |
|
| 2013 |
Kim JY, Ash RT, Ceballos-Diaz C, Levites Y, Golde TE, Smirnakis SM, Jankowsky JL. Viral transduction of the neonatal brain delivers controllable genetic mosaicism for visualising and manipulating neuronal circuits in vivo. The European Journal of Neuroscience. 37: 1203-20. PMID 23347239 DOI: 10.1111/Ejn.12126 |
0.303 |
|
| 2013 |
Puligedda RD, Levites Y, O'Nuallain B, Ondrejcak T, Cruz P, Ladd T, Rowan M, Dessain S. A naturally occurring human IgG specific for oligomeric and fibrillar beta-amyloid: In vitro and in vivo studies Alzheimers & Dementia. 9: 857. DOI: 10.1016/J.Jalz.2013.08.177 |
0.349 |
|
| 2013 |
Sahara N, Levites Y, Sinyavskiy G, Rosario A, Cruz P, Golde T. O2-08-04: Extracellular versus intracellular anti-tau immunotherapy effects in rTg4510 tau transgenic mice Alzheimer's & Dementia. 9: P330-P331. DOI: 10.1016/J.Jalz.2013.04.180 |
0.388 |
|
| 2012 |
Cao L, Schrank BR, Rodriguez S, Benz EG, Moulia TW, Rickenbacher GT, Gomez AC, Levites Y, Edwards SR, Golde TE, Hyman BT, Barnea G, Albers MW. Aβ alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo. Nature Communications. 3: 1009. PMID 22910355 DOI: 10.1038/Ncomms2013 |
0.38 |
|
| 2012 |
Moore BD, Chakrabarty P, Levites Y, Kukar TL, Baine AM, Moroni T, Ladd TB, Das P, Dickson DW, Golde TE. Overlapping profiles of Aβ peptides in the Alzheimer's disease and pathological aging brains. Alzheimer's Research & Therapy. 4: 18. PMID 22621179 DOI: 10.1186/Alzrt121 |
0.417 |
|
| 2012 |
Boddapati S, Levites Y, Suryadi V, Kasturirangan S, Sierks MR. Bispecific tandem single chain antibody simultaneously inhibits β-secretase and promotes α-secretase processing of AβPP. Journal of Alzheimer's Disease : Jad. 28: 961-9. PMID 22156046 DOI: 10.3233/Jad-2011-111196 |
0.372 |
|
| 2011 |
Boddapati S, Levites Y, Sierks MR. Inhibiting β-secretase activity in Alzheimer's disease cell models with single-chain antibodies specifically targeting APP. Journal of Molecular Biology. 405: 436-47. PMID 21073877 DOI: 10.1016/J.Jmb.2010.10.054 |
0.457 |
|
| 2011 |
Levites Y, Jansen K, Ceballos-Diaz C, Cruz P, Adekar S, Dessain S, Golde T. P2-473: Novel methods to develop human monoclonal anti-amyloid antibodies that target Aβ aggregates Alzheimer's & Dementia. 7: S464-S464. DOI: 10.1016/J.Jalz.2011.05.1345 |
0.405 |
|
| 2010 |
Chakrabarty P, Jansen-West K, Beccard A, Ceballos-Diaz C, Levites Y, Verbeeck C, Zubair AC, Dickson D, Golde TE, Das P. Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 548-59. PMID 19825975 DOI: 10.1096/Fj.09-141754 |
0.471 |
|
| 2009 |
Sudol KL, Mastrangelo MA, Narrow WC, Frazer ME, Levites YR, Golde TE, Federoff HJ, Bowers WJ. Generating differentially targeted amyloid-beta specific intrabodies as a passive vaccination strategy for Alzheimer's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 2031-40. PMID 19638957 DOI: 10.1038/Mt.2009.174 |
0.318 |
|
| 2009 |
Golde TE, Das P, Levites Y. Quantitative and mechanistic studies of Abeta immunotherapy. Cns & Neurological Disorders Drug Targets. 8: 31-49. PMID 19275635 DOI: 10.2174/187152709787601830 |
0.466 |
|
| 2009 |
Leissring MA, Reinstatler L, Sahara T, Sevlever D, Roman R, Ji Z, Li L, Lu Q, Säftig P, Levites Y, Golde TE, Burgess J, Ertekin-Taner N, Eckman EA. O4-03-07: Cathepsin D knockout mice harbor large and highly selective increases in cerebral Aß42 and tau: Implications for Alzheimer's disease pathogenesis Alzheimer's & Dementia. 5: P155-P156. DOI: 10.1016/J.Jalz.2009.05.537 |
0.392 |
|
| 2008 |
Kim J, Miller VM, Levites Y, West KJ, Zwizinski CW, Moore BD, Troendle FJ, Bann M, Verbeeck C, Price RW, Smithson L, Sonoda L, Wagg K, Rangachari V, Zou F, et al. BRI2 (ITM2b) inhibits Abeta deposition in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 6030-6. PMID 18524908 DOI: 10.1523/Jneurosci.0891-08.2008 |
0.491 |
|
| 2008 |
Youdim MBH, Levites Y, Weinreb O, Mandel S. c‐DNA Microarray to determine molecular events in neurodegeneration and neuroprotection Journal of Neurochemistry. 81: 4-4. DOI: 10.1046/J.1471-4159.2002.00014.X |
0.308 |
|
| 2008 |
Zou F, Kim J, Miller VM, Levites Y, Ma L, Cangemi D, Bisceglio G, Younkin S, Pankratz VS, Petersen RC, Graff-Radford N, Dickson D, Rosenberry T, Golde T, Younkin SG. P3-276: BRI2 (ITM2B) shows genetic association with late-onset Alzheimer's disease Alzheimer's & Dementia. 4: T603-T603. DOI: 10.1016/J.Jalz.2008.05.1844 |
0.338 |
|
| 2008 |
Miller VM, Kim J, Zou F, Levites Y, Jansen-West K, Zwizinski CW, Moore BD, Troendle FJ, Bann M, Verbeeck C, Price R, Smithson L, Rangachari V, Sonoda L, Wagg K, et al. P2-347: BRI2 (ITM2B) inhibits Aβ deposition Alzheimer's & Dementia. 4: T474-T475. DOI: 10.1016/J.Jalz.2008.05.1424 |
0.372 |
|
| 2008 |
Levites Y, Jansen K, Ceballos C, Golde TE. P2-303: Anti-amyloid single chain fragments as a tool to target Abeta deposition in APP mouse models Alzheimer's & Dementia. 4: T461-T461. DOI: 10.1016/J.Jalz.2008.05.1380 |
0.43 |
|
| 2007 |
Laifenfeld D, Patzek LJ, McPhie DL, Chen Y, Levites Y, Cataldo AM, Neve RL. Rab5 mediates an amyloid precursor protein signaling pathway that leads to apoptosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 7141-53. PMID 17611268 DOI: 10.1523/Jneurosci.4599-06.2007 |
0.417 |
|
| 2006 |
Levites Y, Jansen K, Smithson LA, Dakin R, Holloway VM, Das P, Golde TE. Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 11923-8. PMID 17108166 DOI: 10.1523/Jneurosci.2795-06.2006 |
0.499 |
|
| 2006 |
Levites Y, Smithson LA, Price RW, Dakin RS, Yuan B, Sierks MR, Kim J, McGowan E, Reed DK, Rosenberry TL, Das P, Golde TE. Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse models. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 2576-8. PMID 17068112 DOI: 10.1096/Fj.06-6463Fje |
0.438 |
|
| 2006 |
Das P, Smithson LA, Price RW, Holloway VM, Levites Y, Chakrabarty P, Golde TE. Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Abeta immunotherapy. Journal of Neuroinflammation. 3: 17. PMID 16872492 DOI: 10.1186/1742-2094-3-17 |
0.367 |
|
| 2006 |
Levites Y, Das P, Price RW, Rochette MJ, Kostura LA, McGowan EM, Murphy MP, Golde TE. Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model. The Journal of Clinical Investigation. 116: 193-201. PMID 16341263 DOI: 10.1172/Jci25410 |
0.451 |
|
| 2006 |
Fowlkes KL, Mastrangelo MA, Narrow WC, Levites Y, Golde TE, Federoff HJ, Bowers WJ. 247. Devising Aβ-Specific Passive Immunization Strategies for Alzheimer's Disease Using rAAV Vector-Mediated scFv Antibody Delivery Molecular Therapy. 13: S94-S95. DOI: 10.1016/J.Ymthe.2006.08.274 |
0.439 |
|
| 2006 |
Futch HS, Kuhn MZ, Levites Y, Moore BD, Janus C, Golde TE. P2-063: A NOVEL IMMUNOTHERAPEUTIC APPROACH TO SIMULTANEOUSLY TARGET BEHAVIORAL STRESS AND DOWNSTREAM PATHOLOGIES IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P690-P691. DOI: 10.1016/J.Jalz.2018.06.748 |
0.344 |
|
| 2006 |
Nyborg AC, Levites Y, Ladd TB, Zwizinski CW, Jansen K, Golde TE. O3-03-03: Sortilin, SorLA, SorCS1: Just novel gamma-secretase substrates or more intimately involved in AD pathogenesis? Alzheimer's & Dementia. 2: S57-S57. DOI: 10.1016/J.Jalz.2006.05.207 |
0.346 |
|
| 2006 |
Levites Y, Das P, Smithson LA, Golde TE. P4-291: Anti-Abeta immunotherapy: Quantitative evaluation of acute effects in young TG2576 mice Alzheimer's & Dementia. 2: S602-S602. DOI: 10.1016/J.Jalz.2006.05.2030 |
0.361 |
|
| 2004 |
Levites Y, Das P, Golde TE. P-346 Anti-A1–16, Aβ35–40 and Aβ35–42 single-chain variable region fragments as potential therapeutic agents for AD Neurobiology of Aging. 25: S573. DOI: 10.1016/S0197-4580(04)81904-3 |
0.33 |
|
| 2003 |
Levites Y, Amit T, Mandel S, Youdim MB. Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 952-4. PMID 12670874 DOI: 10.1096/Fj.02-0881Fje |
0.313 |
|
| 2002 |
Youdim MB, Grünblatt E, Levites Y, Maor G, Mandel S. Early and late molecular events in neurodegeneration and neuroprotection in Parkinson's disease MPTP model as assessed by cDNA microarray; the role of iron. Neurotoxicity Research. 4: 679-689. PMID 12709306 DOI: 10.1080/1029842021000045507 |
0.328 |
|
| 2002 |
Levites Y, Amit T, Youdim MB, Mandel S. Involvement of protein kinase C activation and cell survival/ cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. The Journal of Biological Chemistry. 277: 30574-80. PMID 12058035 DOI: 10.1074/Jbc.M202832200 |
0.302 |
|
| Show low-probability matches. |